Active — Not RecruitingNot Applicable

Clinical and Fundamental Aspects of Prosthetics and Translocation of Mitral Valve Chordae

Russia64 participantsStarted 2018-07-09

Plain-language summary

The study compares the efficacies of two surgical procedures for the treatment of mitral valve prolapse due to myxomatous degeneration of the mitral valve: the chordae replacement and the translocation of secondary mitral valve chordae.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. Isolated type II mitral valve insufficiency by A. Carpentier
✓. Mitral regurgitation degree \>2
✓. Age \>18 years
✓. Signed informed consent to participate in the study

Exclusion criteria

✕. Any other cardiac surgeries
✕. Age \<18 years
✕. Multiple organ failure
✕. ReDo procedure
✕. Persistent atrial fibrillation
✕. Acute infective endocarditis
✕. Refusal to sign informed consent

What they're measuring

Mitral regurgitation degree measure

Timeframe: Two weeks

Trial details

NCT IDNCT03674593

SponsorTomsk National Research Medical Center of the Russian Academy of Sciences

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2025-12-31

View on ClinicalTrials.gov More Degenerative Mitral Valve Disease trials